Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 9/20 | 0.51 |
| ▸ | TMIGD3 | P0DMS9 | 3/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.41 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.41 |
| ▸ | PELI1 | Q96FA3 | 2/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.37 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.37 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.37 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.37 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.37 |
| ▸ | TOP2A | P11388 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL609426 | 0.82 | ERN1 (0.49) | ERN1PELI1PTPRCTRIM24TRIM33 | |
| SCHEMBL7525014 | 0.80 | ERN1 (0.48) | ERN1TMIGD3ADORA2AADORA1PELI1 | |
| SCHEMBL31152506 | 0.78 | ERN1 (0.67) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL16439936 | 0.78 | ERN1 (0.67) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL1043113 | 0.77 | ERN1 (0.55) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL31364059 | 0.77 | ERN1 (0.55) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL7528504 | 0.76 | CA1 (0.49) | ERN1TLR2TLR1TLR6 | |
| SCHEMBL1423844 | 0.76 | ERN1 (0.50) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL28918738 | 0.75 | ERN1 (0.49) | ERN1TMIGD3ADORA2AADORA1PTPRC | |
| SCHEMBL6763494 | 0.74 | ERN1 (0.44) | ERN1TMIGD3ADORA2AADORA1PELI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187824-B1 | NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS | PF MEDICAMENT (FR) | 2002-11-13 | — | — | EP | disclosed |
| US-6417222-B1 | DRUGS FOR PSYCHOLOGICAL DISORDERS OR COGNITION ACTIVATORS | PIERRE FABRE MEDICAMENT (FR) | 2002-07-09 | — | — | US | disclosed |
| EP-1187824-A2 | NOVEL (2-SUBSTITUTED-5 - 3-THIENYL) -BENZYL]- 2- ( 2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS | PIERRE FABRE MEDICAMENT (FR) | 2002-03-20 | — | — | EP | disclosed |
| WO-2000058282-A2 | NOVEL [(2-SUBSTITUTED-5 -[3-THIENYL) -BENZYL]-[2- ([2-ISOPROPOXY-5-FLUORO] -PHENOXY) -ETHYL] -AMINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS | PIERRE FABRE MEDICAMENT (FR) | 2000-10-05 | — | — | WO | disclosed |